Finally, prospective studies are necessary to validate our findings on independent cohorts, to investigate a correlation between CDK7 protein expression and sensitivity towards CDK7 inhibition, and to unravel molecular mechanisms by which CDK7 contributes to poor prognosis in NSCLC. This evidence concerns the gene CDK7 and non-small cell lung carcinoma.